NCT00482261 2024-11-08A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for MyelosuppressionPeter MacCallum Cancer Centre, AustraliaPhase 2 Completed150 enrolled